[Edaily Starin Gim Ga Yeong Reporter] Amid the ongoing controversy surrounding actress Ha Young’s great-grandfather, the Netflix series *Such a Shitty Love*, in which she stars, has climbed to the top spot.
According to Netflix’s official site, Tudum, on the 19th, the Netflix series “Such a Shitty Love” ranked No. 1 globally among non-English TV shows, recording 7.5 million views (viewing time divided by runtime) from the 10th to the 16th. Total viewing time was tallied at 88 million. The series reached No. 1 in 26 countries and ranked in the top 10 in 68 countries, including Argentina, Bolivia, Brazil, Chile, Colombia, Peru, Paraguay, Venezuela, France, Spain, the Czech Republic, and Italy. “Such a Shitty Love” is a romantic comedy depicting the heart-fluttering, sticky-sweet cohabitation of “Go Eun-sae,” a prosecutor suffering from amnesia, and “Jang Tae-ha,” a boxing coach who insists he is her boyfriend. It stars actors Jung Hae-in and Ha Young. However, the series was affected by allegations that Ha Young’s great-grandfather, Ahn Sang-ho, was a pro-Japanese collaborator. Ahn Sang-ho, Ha Young’s great-grandfather, served as a council member of the Daejeong Friendship Association, a pro-Japanese organization, and stated in an interview with the Maeil Shinbo, “I am the same as a Japanese person.” As these actions came to light, criticism also fell on his great-granddaughter, Ha Young. Ultimately, Ha Young and her co-star Jung Hae-in canceled an interview scheduled for the 14th, one day before Liberation Day. Amid this situation, “Such a Shitty Romance” has climbed to the No. 1 spot, drawing significant attention. In addition, tvN’s *Creepy Romance*, starring Park Eun-bin and Yang Se-jong, ranked third. It recorded 4.8 million views and 26.7 million viewing hours. *Creepy Romance* made it into the top 10 in 41 countries.
#NEXTBIOMEDICAL CO., LTD., a company specializing in innovative medical devices, has been named to the Korea Exchange’s “KOSDAQ Rising Star” list for the second consecutive year, once again demonstrat…
Celltrion(068270)Celltrion is strengthening its market dominance in Asia—a leading “Shinhung” (emerging pharmaceutical) market—by leveraging its unrivaled direct-to-market competitiveness. While its f…
#
LGCHEM,LTD is set to begin preclinical research on “GNV205,” an antibody-cytokine fusion candidate acquired from the domestic biotech firm GenuV. The company plans to develop it as a next-gen…